A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina

Chronic Stable Angina Clinical Trial

Official title:

A Psychoeducation Trial for People With Chronic Stable Angina

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00350922
• Other study ID #: 452639
• Status: Active, not recruiting
• Phase: Phase 1
• First received: July 8, 2006
• Last updated: July 8, 2006
• Start date: September 2003
• Est. completion date: November 2005

Study information

• Verified date: November 2005
• Source: University of Toronto
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Ethics Review Committee
• Study type: Interventional

Clinical Trial Summary

The purpose of this clinical trial was to determine the effectiveness of a supportive and educational self-management program for improving health-related quality of life (HRQOL), angina symptoms, and self-efficacy and resourcefulness to self-manage for chronic angina patients. 130 participants were enrolled in the trial for 3 months. The program, entitled the Chronic Angina Self-Management Program, (CASMP) was found effective for improving HRQOL, angina symptoms, and self-efficacy to manage symptoms, compared to usual care.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 130
• Est. completion date: November 2005
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

Medical diagnosis of coronary artery disease CCS Class I-III Angina for at least 6 months Speak, read, understand English -

Exclusion Criteria:

MI/Bypass last 6 months CCS Class IV angina A major cognitive disorder -

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Angina Pectoris
• Angina, Stable
• Chronic Stable Angina

Intervention

Behavioral:
• Psychoeducation

Locations

Country	Name	City	State
Canada	University of Toronto	Toronto	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
University of Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	SF36
Primary	Seattle Angina Questionnaire
Secondary	Self-Efficacy Scale
Secondary	Self-Control Schedule